Clover Health Investments, Corp.

NASDAQ:CLOV

Medical - Healthcare Plans

Healthcare
$4.17 +3.54%

+$0.17 today

Market cap
$2.21B
Beta
2.48
P/E (TTM)
-45.6
EPS (TTM)
-$0.11
52W Low $1.58High $5.18

Volume 8.05M

Average 7.31M

CLOV EBITDA Margin

EBITDA as a percentage of revenue.

Clover Health Investments, Corp.NASDAQ: CLOV

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 3.8%

EBITDA Margin was 3.8% in Q2 FY2026, up 6.0 pp from a year earlier. On a trailing-twelve-month basis it was -0.7%, up 1.9 pp year over year. Over 3 fiscal years it widened by 18.6 pp.

Context

  • EBITDA Margin widened in 2 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 3 analysts of 1.4% for the fiscal year ending Dec 2026, up from -4.4% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
3.8%+0.1 pp QoQ
Last fiscal yearDec 2025
-4.4%-1.1 pp YoY
LTMJun 2026
-0.7%+1.9 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.0 pp+4.5 pp-1.4 pp
1 year-1.1 pp+5.7 pp+6.8 pp
3 years+18.6 pp+7.3 pp-11.3 pp
5 years+8.4 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-4.4%
Year-over-year change
-1.1pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How CLOV compares with its peers on the latest reported figures

  • CLOV's LTM Jun 2026 EBITDA Margin of -0.7% is the 6th highest of the 7 companies compared; the peer median is 2.7%.
  • Its year-over-year change of +1.9 pp is the 3rd highest of 7, against a peer median of -0.3 pp.
  • Over three fiscal years its change of +18.6 pp compares with a peer median of -1.7 pp.
CLOV Competitors Peer median
EBITDA Margin for CLOV and competitors
Company Period LTM level YoY 3-year change
CICigna CorporationLTM Sep 20264.4% -0.2 pp-2.1 pp
OSCROscar Health, Inc.LTM Jun 20264.1% +5.0 pp+10.5 pp
CVSCVS Health CorporationLTM Jun 20263.2% -0.4 pp-1.4 pp
HUMHumana Inc.LTM Sep 20262.1% -0.4 pp-2.9 pp
ALHCAlignment Healthcare, Inc.LTM Mar 20261.6% +2.9 pp+9.1 pp
CLOVClover Health Investments, Corp.LTM Jun 2026-0.7% +1.9 pp+18.6 pp
CNCCentene CorporationLTM Jun 2026-1.4% -4.0 pp-5.5 pp
Peer median (excluding CLOV) 2.7%-0.3 pp-1.7 pp

Competitors are the stored peer set for CLOV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.47B1.1B1.26B1.37B1.92B
Cost of Revenue1.55B993.07M1B1.01B1.57B
Gross Profit(79.18M)103.48M255.95M364.8M355.88M
Gross Margin-5.4%9.4%20.3%26.6%18.5%
Research & Development00000
Selling, General & Admin445.75M482.4M440.25M408.93M176.32M
Operating Expenses557.81M390.14M461.28M410.55M441.43M
Depreciation & Amortization1.25M1.19M2.51M1.33M1.69M
EBITDA(569.6M)(252.03M)(207.63M)(44.94M)(83.86M)
EBITDA Margin-38.7%-23.0%-16.5%-3.3%-4.4%
Operating Income(636.99M)(286.66M)(205.33M)(45.75M)(85.53M)
Operating Margin-43.3%-26.1%-16.3%-3.3%-4.4%
Interest Income00000
Interest Expense16.91M1.36M7K00
Other Income / Expenses49.24M32.08M(4.82M)(517K)(20K)
Income Before Tax(587.76M)(254.58M)(210.15M)(46.27M)(85.55M)
Pre-Tax Margin-39.9%-23.2%-16.7%-3.4%-4.4%
Income Tax Expense00000
Net Income(587.76M)(339.57M)(213.36M)(43.01M)(85.55M)
Net Margin-39.9%-31.0%-16.9%-3.1%-4.4%
EPS (Basic)(1.25)(0.71)(0.45)(0.09)(0.17)
EPS (Diluted)(1.25)(0.71)(0.45)(0.09)(0.17)
Weighted Avg Shares470.85M476.24M482.18M490.02M517.24M
Weighted Avg Shares (Diluted)470.85M476.24M482.18M490.02M517.24M

Clover Health Investments, Corp.

NASDAQ:CLOV

Intrinsic Alpha fair value

Locked

Current Price

$4.17

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.